by Jon Fleetwood, Jon Fleetwood:
Meningitis vaccines routinely administered to adolescents across the United States—Menactra, Menveo, and MenQuadfi—are manufactured using bacterial systems that produce toxins, combined with toxin-derived carrier proteins, and processed using formaldehyde, according to FDA prescribing documents.
At the same time, those same FDA inserts list post-vaccination adverse events that mirror the clinical presentation of meningitis, including fever, headache, malaise, vomiting, irritability, and neurological symptoms.
TRUTH LIVES on at https://sgtreport.tv/
Manufacturing Involves Toxins at Multiple Stages
All three vaccines—Menactra, Menveo, and MenQuadfi—are meningococcal conjugate vaccines, meaning they are built using:
- Bacterial components from Neisseria meningitidis
- Carrier proteins derived from bacterial toxins
- Chemical processing steps involving formaldehyde
1. Endotoxin Exposure During Production
The manufacturing process requires growing Neisseria meningitidis bacteria.
These bacteria inherently produce lipooligosaccharide (LOS) endotoxin, a potent inflammatory toxin.
Meaning:
- During production, toxin-containing bacterial cultures are present
- Downstream purification is required to reduce endotoxin levels
Toxins are present during manufacturing by design.
Moreover, high doses of LOS in the bloodstream can cause endotoxemia, leading to severe inflammation, fever, cytokine storms, septic shock, multi-organ failure, and potentially death, as seen in meningococcal disease.
2. Toxin-Derived Carrier Proteins Are Used Intentionally
All three popular meningitis vaccines use proteins derived from bacterial toxins as part of their final formulation:
- Menactra → diphtheria toxoid
- Menveo → CRM197 (genetically modified diphtheria toxin)
- MenQuadfi → tetanus toxoid
From the Menactra insert:
“Meningococcal… Polysaccharide Diphtheria Toxoid Conjugate Vaccine”
From the Menveo insert:
“Oligosaccharide Diphtheria CRM197 Conjugate Vaccine”
From the MenQuadfi insert (warnings section referencing composition):
“…any other tetanus toxoid-containing vaccine”
Each dose contains material that originates from bacterial toxins, even if modified.
3. Formaldehyde Is Used in the Process
Formaldehyde is used in vaccine manufacturing, purportedly to:
- Detoxify bacterial toxins (e.g., diphtheria or tetanus toxins)
- Stabilize biological materials
Residual amounts can remain in the final product.
Formaldehyde is a dangerous chemical known to cause headaches, irritation, nausea, and neurological symptoms, the same categories of symptoms listed in the meningitis vaccine inserts.
Read More @ jonfleetwood.substack.com
